Skip to content

A Study to Evaluate Ayurvedic Multimodal Treatment for Benign Prostatic Enlargement.

A multimodal Ayurvedic management of Benign Prostatic Hyperplasia (BPH): A single arm pre post clinical study design. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104133
Enrollment
20
Registered
2026-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Sponsors

J S Ayurveda Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Only male patient having confirmed diagnosis of Benign prostatic hyperplasia (BPH) will be included. Patient of DM less than 8.0 percentage HBA1C.

Exclusion criteria

Exclusion criteria: Patients with Prostate malignancy; Developmental defects of Prostate, Urethral stricture, CKD, HIV, Hepatic failure, CCF, IHD Patient of DM greater than 8.0 percentage HBA1C.

Design outcomes

Primary

MeasureTime frame
Change in IPSS (International prostate symptom score) before and after multimodal ayurvedic management in patients of Benign prostatic hyperplasia (BPH).Timepoint: Total duration of 2 months including 1 month of I.P.D. and 1 month of O.P.D. treatment.

Secondary

MeasureTime frame
Change in USG prostate volume, PVR and Quality of life score improvement before and after multimodal ayurvedic management in patients of Benign prostatic hyperplasia (BPH).Timepoint: Total duration of 2 months including 1 month of I.P.D. and 1 month of O.P.D. treatment.

Countries

India

Contacts

Public ContactProf Dr Dhaval Dholakiya

J S Ayurveda Mahavidyalaya and P D Patel Ayurvedic Hospital Nadiad

vddhavaldholakiya1910@gmail.com89890925520

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026